🦊/Investors

NCL Technology Ventures Ltd. β€” Full Portfolio

11 tracked investments Β· listed companies and verified rows first

Ampersand Healthampersandhealth.co.ukin𝕏

Ampersand provides a digital platform for remote patient monitoring and clinician communication, enabling healthcare teams to track symptoms, deliver digital therapies, and manage patient care in outpatient settings.

Digital HealthHealthtechWellness & FitnessNashville, US

Lang Aston(Executive Officer)Timothy M. Petrikin(Executive Officer, Director)J. Lang Aston(Executive Officer, Director)W. Bradley Rouse(Executive Officer, Director)

BoardJack Tyrell(Director)Philip Hertik(Director)

Co-investorsSimplyhealth Ventures

Azadyneazadyne.comin

Azadyne is a UK biotech company and spin-out from Trinity College Dublin developing therapeutics based on tRNA modification and epigenetic regulation of cellular protein synthesis.

BiotechDeep Tech

Vincent KellyStephen Connonin

BoardJason Rutt

Co-investors24 Haymarket

Centauri Therapeuticscentauritherapeutics.comin

Centauri Therapeutics develops the Alphamer platform, a proprietary antibody recruiting molecule technology designed to redirect the immune system against disease targets.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsAMR Action FundBoehringer Ingelheim Venture Fund

Curesponsecuresponse.cominJun 2020 Β· $6M

Curesponse applies science and technology to improve cancer treatment, bringing together medical executives, scientists, and clinical and regulatory experts.

AI & Machine LearningBiotechDigital HealthHealthtech

Guy Neev(Co-Founder & CEO)inDr. Ravid Straussman(Scientific Founder)Dr. Seth Salpeter(Co-Founder & CTO)Eran Dor(CFO)

Co-investorsaMoon

Emteq Labsemteqlabs.comin𝕏

Emteq Labs develops wearable technology that monitors and translates facial expressions to measure emotional and behavioral responses in real-world settings.

AI & Machine LearningDigital HealthHardwareHealthtechBrighton, GB

Dr Charles Nduka(Chief Science Officer (CSO) and founder)

Co-investorsInnovate UK

Revolobiorevolobio.comin𝕏

Revolo Biotherapeutics develops immunomodulatory therapies targeting allergic and immune-mediated conditions.

BiotechHealthtechMedical Devices

Jonathan Rigby(Employee #1)

Co-investors24 Haymarket

Sana Healthsana.ioin

Sana Health develops an audiovisual device intended to help users improve physical recovery and mental well-being, targeting relief and more restful states of mind.

Digital HealthHealthtechMedical DevicesMental HealthLafayette, US

Richard Hanbury(Founder)in

Co-investorsCheckmate Capital Group LLCClick VenturesFlucas VenturesHarmonix FundHealthtech CapitalMarram Ventures+5 more

TC Biopharmtcbiopharm.comNov 2022

Developing a scalable off-the-shelf allogeneic gamma delta T cell therapy platform.

BiotechHolytown, Motherwell

Martin Thorp(Executive Officer, Director)Edward Niemczyk(Director)Mark Bonyhadi(Director)Michael Leek(Director)Arlene Morris(Director)James Culverwell(Director)

Co-investorsInvesting Women AngelsCrowdcubeScottish Enterprise

Viramalviramal.com

Viramal develops proprietary products for women's sexual, vaginal, and reproductive health using its Fem Med Tech platform.

BiotechFemTechHealthtech

Oliver Bates(Chief Executive Officer and Co-founder)in

Other

Tracked investments with no reachable website or further public details β€” typically companies that wound down, renamed, or were absorbed.

RevoloViramel

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.